Hirotsu Bio Science

Tokyo, Japan · Founded 2016 · Privately Held (backing)

Developer of a cancer detection technology designed to identify small amounts of cancerous odors in urine with high accuracy. Hirotsu Bio Science is based in Tokyo, Japan and was founded in 2016. Its last reported valuation was $500 million in Jan 2025. It has raised $126 million.

Last reported valuation

$500.0M

Oct 2026

Priced at

—

Total raised

$125.5M

Last round

—

How much has Hirotsu Bio Science raised?

$125.5Macross 0 recorded rounds

Free account

More of Hirotsu Bio Science with a free account

·The complete investor list: 19 names
·Watch Hirotsu Bio Science: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Hirotsu Bio Science investors

19 investors are on record for Hirotsu Bio Science, including SBI Investment, Mitsui Sumitomo Insurance Co., Shinkin Capital and Aioi Nissay Dowa Insurance.

For fundraisers

Raising for a company like Hirotsu Bio Science?

19 investors have backed Hirotsu Bio Science.

See all 19 investors →

Frequently asked about Hirotsu Bio Science

How much has Hirotsu Bio Science raised?: Hirotsu Bio Science has raised $125.5M in total across 0 recorded funding rounds.